JP2002325853A5 - - Google Patents

Download PDF

Info

Publication number
JP2002325853A5
JP2002325853A5 JP2002061784A JP2002061784A JP2002325853A5 JP 2002325853 A5 JP2002325853 A5 JP 2002325853A5 JP 2002061784 A JP2002061784 A JP 2002061784A JP 2002061784 A JP2002061784 A JP 2002061784A JP 2002325853 A5 JP2002325853 A5 JP 2002325853A5
Authority
JP
Japan
Prior art keywords
acetic acid
pharmaceutical kit
kit according
xanthenone
photodynamic compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002061784A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002325853A (ja
Filing date
Publication date
Priority claimed from US09/801,163 external-priority patent/US6495585B2/en
Application filed filed Critical
Publication of JP2002325853A publication Critical patent/JP2002325853A/ja
Publication of JP2002325853A5 publication Critical patent/JP2002325853A5/ja
Pending legal-status Critical Current

Links

JP2002061784A 2001-03-07 2002-03-07 哺乳類の過剰増殖組織を処理するための方法 Pending JP2002325853A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/801163 2001-03-07
US09/801,163 US6495585B2 (en) 2001-03-07 2001-03-07 Method for treating hyperproliferative tissue in a mammal

Publications (2)

Publication Number Publication Date
JP2002325853A JP2002325853A (ja) 2002-11-12
JP2002325853A5 true JP2002325853A5 (cg-RX-API-DMAC10.html) 2005-09-02

Family

ID=25180358

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002061784A Pending JP2002325853A (ja) 2001-03-07 2002-03-07 哺乳類の過剰増殖組織を処理するための方法

Country Status (5)

Country Link
US (1) US6495585B2 (cg-RX-API-DMAC10.html)
EP (1) EP1238666B1 (cg-RX-API-DMAC10.html)
JP (1) JP2002325853A (cg-RX-API-DMAC10.html)
AT (1) ATE295163T1 (cg-RX-API-DMAC10.html)
DE (1) DE60204067T2 (cg-RX-API-DMAC10.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39094E1 (en) 1988-07-20 2006-05-09 Health Research, Inc. Pyropheophorbides and their use in photodynamic therapy
USRE38994E1 (en) 1988-07-20 2006-02-28 Health Research, Inc. Pyropheophorbides conjugates and their use in photodynamic therapy
EP1131100B1 (en) * 1999-01-15 2003-03-12 Light Sciences Corporation Therapeutic compositions for metabolic bone disorders or bone metastases comprising a photosensitizer and a bisphosphonate
US6602274B1 (en) 1999-01-15 2003-08-05 Light Sciences Corporation Targeted transcutaneous cancer therapy
US20030114434A1 (en) * 1999-08-31 2003-06-19 James Chen Extended duration light activated cancer therapy
US7897140B2 (en) 1999-12-23 2011-03-01 Health Research, Inc. Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
CA2395567A1 (en) 2000-01-12 2001-07-19 Light Sciences Corporation Novel treatment for eye disease
WO2004002476A2 (en) 2002-06-27 2004-01-08 Health Research, Inc. Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy
US7053210B2 (en) 2002-07-02 2006-05-30 Health Research, Inc. Efficient synthesis of pyropheophorbide a and its derivatives
US20080114021A1 (en) * 2006-11-09 2008-05-15 University Of Maryland Baltimore Use Of 5,6-Dimethylxanthenone-4-Acetic Acid as an Antimicrobial Agent
US8180444B2 (en) * 2007-06-22 2012-05-15 Biolitec Pharma Marketing Ltd Enhanced PhotoDynamic Therapy with immune system assist
WO2010045551A1 (en) * 2008-10-17 2010-04-22 Concert Pharmaceuticals, Inc. Xanthenone-4-acetic acid derivatives
CN109289048B (zh) * 2018-08-08 2021-05-25 南京工业大学 一种肿瘤血管阻断协同光治疗试剂及其合成方法与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649151A (en) * 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
US5002962A (en) * 1988-07-20 1991-03-26 Health Research, Inc. Photosensitizing agents
GB9308166D0 (en) * 1993-04-20 1993-06-02 Cancer Res Campaign Tech Cancer therapy

Similar Documents

Publication Publication Date Title
DE60233140D1 (de) Nitrosiertes und nitrosyliertes nebivolol und seine metaboliten, zusammensetzungen und anwendungsverfahren
AU4327300A (en) Prostaglandin compounds, compositions and methods of treating peripheral vascular disease and pulmonary hypertension
NO20020764D0 (no) Benzoesyrederivater for behandling av diabetes mellitus
MXPA03006728A (es) Combinaciones de inhibidor(es) de la absorcion de esterol con modificador(es) sanguineos para tratar cuadros vasculares.
JP2006502236A5 (cg-RX-API-DMAC10.html)
CY1112049T1 (el) Χρηση ανθρακικου λανθανιου για την προληψη της νεφρικης λιθιασικης νοσου
WO2006060809A3 (en) Methods of using [3.2.0] heterocyclic compounds and analogs thereof
JP2004502684A5 (cg-RX-API-DMAC10.html)
CA2339384A1 (en) Improved method for targeted topical treatment of disease
EA200401303A1 (ru) Лекарственные средства, содержащие стероиды и новое антихолинергическое средство
DK1330244T3 (da) Præparater der omfatter modafinilforbindelser
EP1238666A3 (en) Use of xanthenone-4-acetic acid in the manufacture of a medicament in the treatment of hyperproliferative disorders
WO1998041649A3 (en) Rapid method of cancer diagnosis
RU99125040A (ru) Сульфозамещенные фталоцианины как фотосенсибилизаторы для фотодинамической терапии
JP2005525397A5 (cg-RX-API-DMAC10.html)
RU2000108978A (ru) Способ лечения гастродуоденальных язв, осложненных рубцовоязвенным стенозом верхних отделов желудочно-кишечного тракта
DE69732230D1 (de) Durch lymphe absorbierbare imidazolderivate
NO20033273L (no) Anvendelse av (R)-ibuprofen-metansulfonamid og salter derav til behandlingog forhindring av avstötning av transplanterte organer
DE69635806D1 (de) Diphosphonat derivate von therapeutisch wirksamen stoffen
CA2385301A1 (en) Peeling composition
WO2001040234A1 (en) Porphyrin compound
RU2003108472A (ru) Средство ранней патогенетической терапии острой лучевой болезни
WO2000073274A3 (de) Substituierte phenylcyclohexancarbonsäureamide und ihre verwendung als adenosinaufnahme-inhibitoren
ATE516038T1 (de) Metallcluster-nanoverbindungen zur behandlung von tumorerkrankungen
RU99113773A (ru) Способ лечения ожогового шока